(1)
Blauvelt, A. .; Pink, A. .; Worm, M.; Langley, R.; Costanzo, A.; Gjerum, L.; Jorgensen, E.; Corriveau, J.; Guttman-Yassky, E. COVID-19 in Tralokinumab-Treated Patients With Moderate-to- Severe Atopic Dermatitis: Case Series from the ECZTEND Long- Term Extension Trial. J of Skin 2021, 5, s58.